➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
Mallinckrodt
Dow
McKinsey

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Pharmacyclics LLC v. Cipla Limited (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Pharmacyclics LLC v. Cipla Limited (D. Del. 2018)

Small Molecule Drugs cited in Pharmacyclics LLC v. Cipla Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Pharmacyclics LLC v. Cipla Limited

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Pharmacyclics LLC v. Cipla Limited (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-02-01 1 United States Patent Nos. 8,008,309 (“the ’309 Patent”); 7,514,444 (“the ’444 Patent”); 8,697,711 (“…(“the ’711 Patent”); 8,735,403 (“the ’403 Patent”); 8,957,079 (“the ’079 Patent”); 9,181,257 (“the ’257…’257 Patent”); 8,754,091 (“the ’091 Patent”); 8,497,277 (“the ’277 Patent”); 8,952,015 (“the ’015 Patent…37 PageID #: 2 Patent”); 9,296,753 (“the ’753 Patent”); 9,725,455 (“the ’455 Patent”); 9,540,382 (“the… 1. This action for patent infringement, brought pursuant to the patent laws of the United States External link to document
2019-02-14 104 B2 ;9,801,881 B2 ;9,801,883 B2 ;10,125,140 B1 ;10,106,548 B2. (fms) (Entered: 02/14/2019) 14 February… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,296,753 B2 ;…February 2018 1:18-cv-00192-CFC-CJB 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-03-15 128 Answer to Counterclaim Admitted. 17. U.S. Patent No. 10,106,548 (“the ’548 Patent”), on its face, is titled “Crystalline…’753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the…’753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the…’753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the…753 Patent, the ’455 Patent, the ’382 Patent, the ’617 Patent, the ’090 Patent, the ’889 Patent, the External link to document
2019-05-24 161 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,016,435 B2 . (Blumenfeld, …February 2018 1:18-cv-00192-CFC-CJB 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Medtronic
Mallinckrodt
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.